References 1. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H (1990) The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49–59. 2. Yokota Y (2001) Id and development. Oncogene 20: 8290–8298. 3. Ruzinova MB, Benezra R (2003) Id proteins in development, cell cycle and cancer. Trends Cell Biol 13: 410–418. 4. Kreider BL, Benezra R, Rovera G, Kadesch T (1992) Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255: 1700–1702. 5. Wilson RB, Kiledjian M, Shen CP, Benezra R, Zwollo P, et al. (1991) Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development. Mol Cell Biol 11: 6185–6191. 6. Jen Y, Weintraub H, Benezra R (1992) Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev 6: 1466–1479. 7. Lasorella A, Boldrini R, Dominici C, Donfrancesco A, Yokota Y, et al. (2002) Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res 62: 301–306. 8. Daibata M, Matsuo Y, Machida H, Taguchi T, Ohtsuki Y, et al. (2004) Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia. Int J Cancer 108: 845–851. 9. Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, et al. (2001) Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 61: 8803–8810. 10. Nishimori H, Sasaki Y, Yoshida K, Irifune H, Zembutsu H, et al. (2002) The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 21: 8302–8309. 11. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY (2004) Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 10: 2044–2051. 12. Kleeff J, Ishiwata T, Friess H, Buchler MW, Israel MA, et al. (1998) The helix- loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res 58: 3769–3772. 13. Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, et al. (2008) Increased expression of id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 14: 2318–2325. 14. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10–30. 15. Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, et al. (2006) Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 4: 548–582. Expression of ID2 in NSCLC 16. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108. 17. Vielh P, Spano JP, Grenier J, Le Chevalier T, Soria JC (2005) Molecular prognostic factors in resectable non-small cell lung cancer. Crit Rev Oncol Hematol 53: 193–197. 18. Baghdoyan S, Lamartine J, Castel D, Pitaval A, Roupioz Y, et al. (2005) Id2 reverses cell cycle arrest induced by {gamma}-irradiation in human HaCaT keratinocytes. J Biol Chem 280: 15836–15841. 19. Melnikova IN, Bounpheng M, Schatteman GC, Gilliam D, Christy BA (1999) Differential biological activities of mammalian Id proteins in muscle cells. Exp Cell Res 247: 94–104. 20. Liu CJ, Ding B, Wang H, Lengyel P (2002) The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol Cell Biol 22: 2893–2905. 21. Yuen HF, Chua CW, Chan YP, Wong YC, Wang X, et al. (2006) Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases. Mod Pathol 19: 931–941. 22. Stighall M, Manetopoulos C, Axelson H, Landberg G (2005) High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells. Int J Cancer 115: 403–411. 23. Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, et al. (2003) Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. Cancer Res 63: 7098–7105. 24. Perk J, Iavarone A, Benezra R (2005) Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5: 603–614. 25. Kurooka H, Yokota Y (2005) Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors. J Biol Chem 280: 4313–4320. 26. Lasorella A, Iavarone A (2006) The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc Natl Acad Sci U S A 103: 4976–4981. 27. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407: 592–598. 28. Lasorella A, Rothschild G, Yokota Y, Russell RG, Iavarone A (2005) Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol Cell Biol 25: 3563–3574. 29. Hua H, Sarvetnick N (2007) ID2 promotes the expansion and survival of growth-arrested pancreatic beta cells. Endocrine 32: 329–337. 30. Beasley MB, Brambilla E, Travis WD (2005) The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 40: 90–97. PLoS ONE | www.plosone.org 7 January 2009 | Volume 4 | Issue 1 | e4158